Zenas Biopharma Inc (ZBIO) Implied Volatility Current

Tracking ZBIO implied volatility helps you identify when options premiums on Zenas Biopharma Inc are historically cheap or expensive, and where the best trades are hiding. Zenas Biopharma Inc implied volatility reflects the market's expectation of future price movement: when ZBIO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Zenas Biopharma Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ZBIO, tracking metrics like ZBIO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ZBIO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody.

Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ZBIO implied volatility sits today versus where it has been. Our scanner ranks Zenas Biopharma Inc implied volatility against its historical range, surfaces extremes in ZBIO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Zenas Biopharma Inc IV is rich or cheap — measure it, then act on it.